Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nahid Ali

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Cellular Immunology|July 30, 2016
Lipid based delivery and immuno-stimulatory systems: Master tools to combat leishmaniasisAbdus Sabur, Mohammad Asad, Nahid Ali
Vaccine|July 28, 2007
Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 responseSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
Infection and Immunity|January 27, 2009
Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infectionSudipta Bhowmick, Tuhina Mazumdar, Nahid Ali
Molecular Pharmaceutics|December 3, 2011
Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable routeRajesh Ravindran, Mithun Maji, Nahid Ali
BMC Microbiology|January 17, 2014
IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccineSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
Journal of Drug Targeting|December 18, 2008
Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheresPrabhakar Reddy Veerareddy, Venkateswarlu Vobalaboina, Nahid Ali
Immunology and Cell Biology|September 1, 2020
Antibody detection assays for COVID-19 diagnosis: an early overviewSarfaraz Ahmad Ejazi, Sneha Ghosh, Nahid Ali
The Journal of Eukaryotic Microbiology|August 22, 2002
Infectivity and virulence of Leishmania donovani promastigotes: a role for media, source, and strain of parasiteTuhina Dey, Farhat Afrin, Khairul Anam, et al.
BMC Microbiology|June 26, 2010
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasisRajesh Ravindran, Sudipta Bhowmick, Amrita Das, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 13, 2009
Comparison of liposome based antigen delivery systems for protection against Leishmania donovaniSwati Bhowmick, Tuhina Mazumdar, Roma Sinha, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Cellular Immunology|July 30, 2016
Lipid based delivery and immuno-stimulatory systems: Master tools to combat leishmaniasisAbdus Sabur, Mohammad Asad, Nahid Ali
Vaccine|July 28, 2007
Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 responseSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
Infection and Immunity|January 27, 2009
Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infectionSudipta Bhowmick, Tuhina Mazumdar, Nahid Ali
Molecular Pharmaceutics|December 3, 2011
Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable routeRajesh Ravindran, Mithun Maji, Nahid Ali
BMC Microbiology|January 17, 2014
IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccineSudipta Bhowmick, Rajesh Ravindran, Nahid Ali
Journal of Drug Targeting|December 18, 2008
Antileishmanial activity, pharmacokinetics and tissue distribution studies of mannose-grafted amphotericin B lipid nanospheresPrabhakar Reddy Veerareddy, Venkateswarlu Vobalaboina, Nahid Ali
Immunology and Cell Biology|September 1, 2020
Antibody detection assays for COVID-19 diagnosis: an early overviewSarfaraz Ahmad Ejazi, Sneha Ghosh, Nahid Ali
The Journal of Eukaryotic Microbiology|August 22, 2002
Infectivity and virulence of Leishmania donovani promastigotes: a role for media, source, and strain of parasiteTuhina Dey, Farhat Afrin, Khairul Anam, et al.
BMC Microbiology|June 26, 2010
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasisRajesh Ravindran, Sudipta Bhowmick, Amrita Das, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 13, 2009
Comparison of liposome based antigen delivery systems for protection against Leishmania donovaniSwati Bhowmick, Tuhina Mazumdar, Roma Sinha, et al.
Pageof 11